News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
415,461 Results
Type
Article (29958)
Company Profile (118)
Press Release (385385)
Section
Business (105778)
Career Advice (537)
Deals (18620)
Drug Delivery (84)
Drug Development (51531)
Employer Resources (79)
FDA (11496)
Job Trends (10346)
News (192196)
Policy (22015)
Tag
Academia (2139)
Alliances (29138)
Alzheimer's disease (984)
Approvals (11493)
Artificial intelligence (132)
Bankruptcy (155)
Best Places to Work (9247)
Biotechnology (64)
Breast cancer (130)
Cancer (939)
Cardiovascular disease (108)
Career advice (492)
Cell therapy (168)
Clinical research (43153)
Collaboration (364)
COVID-19 (2260)
C-suite (74)
Data (1016)
Diabetes (139)
Diagnostics (4796)
Drug pricing (91)
Earnings (35853)
Employer resources (70)
Events (73767)
Executive appointments (314)
FDA (12086)
Funding (371)
Gene therapy (129)
GLP-1 (423)
Government (4233)
Healthcare (15236)
Infectious disease (2349)
Inflammatory bowel disease (85)
IPO (8028)
Job creations (1510)
Job search strategy (448)
Layoffs (221)
Legal (3975)
Lung cancer (159)
Manufacturing (125)
Medical device (9512)
Medtech (9515)
Mergers & acquisitions (10771)
Metabolic disorders (369)
Neuroscience (1258)
NextGen: Class of 2025 (5075)
Non-profit (3944)
Northern California (1203)
Obesity (212)
Opinion (124)
Parkinson's disease (70)
People (32640)
Phase I (11484)
Phase II (18051)
Phase III (16627)
Pipeline (419)
Postmarket research (1781)
Preclinical (3361)
Radiopharmaceuticals (151)
Rare diseases (211)
Real estate (2878)
Regulatory (15020)
Research institute (1939)
Series A (63)
Southern California (957)
Startups (2125)
United States (11048)
Vaccines (491)
Weight loss (137)
Date
Today (107)
Last 7 days (659)
Last 30 days (1620)
Last 365 days (23449)
2025 (1108)
2024 (23582)
2023 (26328)
2022 (35789)
2021 (39255)
2020 (39396)
2019 (34739)
2018 (26062)
2017 (19358)
2016 (20014)
2015 (22890)
2014 (16964)
2013 (13268)
2012 (14045)
2011 (14494)
2010 (12571)
Location
Africa (522)
Arizona (104)
Asia (22913)
Australia (4135)
California (2612)
Canada (1027)
China (235)
Colorado (133)
Connecticut (157)
Europe (51082)
Florida (393)
Georgia (123)
Illinois (293)
Indiana (224)
Japan (78)
Kansas (74)
Maryland (494)
Massachusetts (2040)
Michigan (119)
Minnesota (180)
New Jersey (913)
New York (819)
North Carolina (561)
Northern California (1203)
Ohio (100)
Pennsylvania (681)
South America (681)
Southern California (957)
Texas (348)
Utah (105)
Washington State (327)
415,461 Results for "endpoint health".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Oculis Announces Positive OCS-05 Phase 2 ACUITY Trial in Acute Optic Neuritis, Met Primary Safety Endpoint and Key Secondary Efficacy Endpoints Opening Development Pathways as a Potential First-in-Class Neuroprotective Therapy
January 6, 2025
·
15 min read
Press Releases
Tonix Pharmaceuticals Announces Participation in Endpoints Panel at the Long COVID Workshop and RECOVER TLC Workshop Convened by the Foundation for the National Institutes of Health (FNIH) and the National Institute of Allergy and Infectious Diseases (NIAID)
October 1, 2024
·
6 min read
Press Releases
Bayer’s investigational MRI contrast agent gadoquatrane meets primary and main secondary endpoints in pivotal Phase III studies
January 10, 2025
·
7 min read
Press Releases
Novartis intrathecal onasemnogene abeparvovec Phase III study meets primary endpoint in children and young adults with SMA
December 30, 2024
·
10 min read
Business
Trials and Capital: Women’s Health and APAC’s Healthcare Revolution
In this episode of Denatured, BioSpace’s Head of Insights Lori Ellis, Miguel Forte and Ali Pashazadeh discuss the industry’s need to catch up with women’s health issues and the innovative lead the APAC region has taken in clinical trials.
January 2, 2025
·
1 min read
·
Lori Ellis
Press Releases
Adaptimmune’s Lete-cel Achieves Primary Endpoint in Pivotal Trial
November 13, 2024
·
8 min read
Press Releases
Press Release: New Sarclisa subcutaneous formulation met co-primary endpoints in the IRAKLIA phase 3 study in multiple myeloma
January 9, 2025
·
10 min read
Press Releases
Elinzanetant Meets All Primary and Secondary Endpoints in Phase III Study OASIS 4 for Treatment of Moderate to Severe Vasomotor Symptoms Caused by Breast Cancer Treatments
January 9, 2025
·
11 min read
Press Releases
Cassava Sciences Topline Phase 3 Data Did Not Meet Co-Primary Endpoints
November 26, 2024
·
8 min read
Drug Development
Agios Announces Phase 3 ENERGIZE-T Study of Mitapivat Met Primary Endpoint and All Key Secondary Endpoints in Adults with Transfusion-Dependent Alpha- or Beta-Thalassemia
Agios Pharmaceuticals, Inc., a leader in cellular metabolism and pyruvate kinase activation pioneering therapies for rare diseases, announced that the global Phase 3 ENERGIZE-T study of mitapivat in adults with transfusion-dependent alpha- or beta-thalassemia achieved its primary endpoint of transfusion reduction response.
June 3, 2024
·
10 min read
1 of 41,547
Next
